Phase II Study of Pralatrexate and Docetaxel in Patients With Advanced Esophageal and Gastroesophageal Carcinoma Who Have Failed Prior Platinum-based Therapy.
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2016
At a glance
- Drugs Docetaxel (Primary) ; Pralatrexate (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 15 Oct 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 12 Nov 2013 Additional lead trial centre added as reported by ClinicalTrials.gov record.
- 12 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.